IP Library Granted Patent US 9,766,198
Granted Patent B2
US 9,766,198 · App. 14/964,827 · Granted Sep 19, 2017

Oxidizable species as an internal reference in control solutions for biosensors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,766,198
App. No.
14/964,827
Granted
Sep 19, 2017
Kind
B2
Abstract

Testing of the performance of an electrochemical meter used to measure the presence of an analyte in a biological sample, particularly glucose in whole blood, includes introducing a control solution containing a predetermined amount of the analyte and a predetermined amount of an internal reference compound. The internal reference compound is selected such that it is oxidized at a potential greater than that used to oxidize the analyte, thereby making it possible to distinguish the control solution from a biological sample.

Claims (25)

1. A method of distinguishing a control solution from a sample during operation of an electrochemical sensor, the electrochemical sensor measuring the amount of an analyte, the method comprising the acts of:

providing an electrochemical sensor having a working electrode, a counter electrode, a reagent, and a control solution, the reagent having a mediator, the control solution having an internal reference compound, a buffer, and a predetermined amount of analyte, the internal reference compound having a higher redox potential than the mediator, the internal reference compound being different from the buffer;

applying a first potential to the electrochemical sensor sufficient to oxidize the internal reference compound and the mediator, and measuring the resulting electrical current;

applying a second, lower potential to the electrochemical sensor, the lower potential being sufficient to oxidize the mediator and insufficient to oxidize the internal reference compound, and measuring the resulting electrical current; and

determining whether a control solution or a sample is present based on the measured electrical currents.

2. The method of claim 1 , wherein the analyte is glucose and the biological sample is whole blood.

3. The method of claim 1 , wherein the internal reference compound is an oxidizable organo-metallic compound, coordination compound, or organic amine compound.

4. The method of claim 3 , wherein the internal reference compound is the organic amine compound, the organic amine compound being 3-(N-morpholino) propane sulfonic acid, N-(2-hydroxyethyl) piperazine-N 1 -(2-ethane sulfonic acid), 2-[(2-Hydroxy-1,1-bis(hydroxy methyl)ethylamino] ethane sulfonic acid, 2-Morpholino ethane sulfonic acid, and Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane [Bis-Tris], 4-aminobenzonitrile, 4-aminobenzoic acid, or 4-iodoaniline.

5. The method of claim 3 , wherein the internal reference compound is the oxidizable organo-metallic compound, the oxidizable organo-metallic compound being ferrocene or ferrocene derivatives.

6. The method of claim 3 , wherein the internal reference compound is the coordination compound, the coordination compound being potassium ferrocyanide.

7. The method of claim 1 , wherein the internal reference compound has a redox potential that is at least 100 mV higher than the redox potential of the mediator.

8. The method of claim 1 , wherein the first potential is at least 100 mV higher than the second potential.

9. The method of claim 1 , wherein the first potential and the second potential are applied without a waiting period therebetween.

10. A method of distinguishing a control solution from a sample during operation of an electrochemical sensor, the electrochemical sensor measuring the amount of an analyte, the method comprising the acts of:

providing an electrochemical sensor having a working electrode, a counter electrode, a reagent, and a control solution, the reagent having a mediator, the control solution having a predetermined amount of an internal reference compound, a buffer, and a predetermined amount of analyte, the predetermined amount of the internal reference compound being dependent upon the predetermined amount of analyte;

applying a first potential to the electrochemical sensor sufficient to oxidize the internal reference compound and the mediator, and measuring the resulting electrical current;

applying a second potential to the electrochemical sensor, the second potential being at least 100 mV lower than the first potential, the second potential being sufficient to oxidize the mediator and insufficient to oxidize the internal reference compound, and measuring the resulting electrical current; and

determining whether a control solution or a sample is present based on the measured electrical currents.

11. The method of claim 10 , wherein the analyte is glucose and the biological sample is whole blood.

12. The method of claim 10 , wherein the internal reference compound is an oxidizable organo-metallic compound, coordination compound, or organic amine compound.

13. The method of claim 12 , wherein the internal reference compound is the organic amine compound, the organic amine compound being 3-(N-morpholino) propane sulfonic acid, N-(2-hydroxyethyl) piperazine-N 1 -(2-ethane sulfonic acid), 2-[(2-Hydroxy-1,1-bis(hydroxy methyl)ethylamino] ethane sulfonic acid, 2-Morpholino ethane sulfonic acid, and Bis(2-hydroxyethyl)amino-tris (hydroxymethyl) methane [Bis-Tris], 4-aminobenzonitrile, 4-aminobenzoic acid, or 4-iodoaniline.

14. The method of claim 12 , wherein the internal reference compound is the oxidizable organo-metallic compound, the oxidizable organo-metallic compound being ferrocene or ferrocene derivatives.

15. The method of claim 12 , wherein the internal reference compound is the coordination compound, the coordination compound being potassium ferrocyanide.

16. The method of claim 10 , wherein the internal reference compound has a redox potential that is at least 100 mV higher than the redox potential required of the mediator.

17. The method of claim 10 , wherein the buffer is different from the internal reference compound, the buffer and the internal reference compound being configured to serve different functions.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2015
From: BEER, GREG; WU, HUAN-PING
To: BAYER HEALTHCARE LLC
Reel/Frame 037348/0813 →